CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination

GLIA

Volumn 59, Issue 12, 2011, Pages 1813-1821

  Carbajal, Kevin S ^a   Miranda, Juan L ^a   Tsukamoto, Michelle R ^a   Lane, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemokine receptors; Chemokines; Oligodendrocytes; Remyelination

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PLERIXAFOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONAVIRUS INFECTION; MALE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NERVE DEGENERATION; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA; PRIMARY CELL CULTURE; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 80053564110     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21225     Document Type: Article

References (50)

1. Adami C, Pooley J, Glomb J, Stecker E, Fazal F, Fleming JO, Baker SC. 1995. Evolution of mouse hepatitis virus (MHV) during chronic infection: Quasispecies nature of the persisting MHV RNA. Virology 209: 337-346.
2. Aharoni R, Herschkovitz A, Eilam R, Blumberg-Hazan M, Sela M, Bruck W, Arnon R. 2008. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 105: 11358-11363.
3. Armstrong RC, Le TQ, Flint NC, Vana AC, Zhou YX. 2006. Endogenous cell repair of chronic demyelination. J Neuropathol Exp Neurol 65: 245-256.
4. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC. 2002. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22: 8574-8585.
5. Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 4: 121-132.
6. Blakemore WF, Keirstead HS. 1999. The origin of remyelinating cells in the central nervous system. J Neuroimmunol 98: 69-76.
7. Bunge MB, Bunge RP, Ris H. 1961. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J Biophys Biochem Cytol 10: 67-94.
8. Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, Berman JW. 2006. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol 177: 27-39.
9. Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE. 2010. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA 107: 11068-11073.
10. Cheever FS, Daniels JB, Pappenheimer AM, Bailey OT. 1949. A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J Exp Med 90: 181-210.
11. De Clercq E. 2003. The bicyclam AMD3100 story. Nat Rev Drug Discov 2: 581-587.
12. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, Allaway GP, Sakmar TP, Henson G, De Clercq E, Moore JP. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 4: 72-77.
13. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M. 2005. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50: 258-269.
14. Frost EE, Nielsen JA, Le TQ, Armstrong RC. 2003. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 54: 457-472.
15. Hardison JL, Nistor G, Gonzalez R, Keirstead HS, Lane TE. 2006. Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Exp Neurol 197: 420-429.
16. Hirano N, Murakami T, Fujiwara K, Matsumoto M. 1978. Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. Jpn J Exp Med 48: 71-75.
17. Huang JK, Jarjour AA, Oumesmar BN, Kerninon C, Williams A, Krezel W, Kagechika H, Bauer J, Zhao C, Evercooren AB, Chambon P, Ffrench-Constant C, Franklin RJ. 2010. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 14: 45-53.
18. Imitola J, Snyder EY, Khoury SJ. 2003. Genetic programs and responses of neural stem/progenitor cells during demyelination: Potential insights into repair mechanisms in multiple sclerosis. Physiol Genomics 14: 171-197.
19. Kadi L, Selvaraju R, de Lys P, Proudfoot AE, Wells TN, Boschert U. 2006. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol 174: 133-146.
20. Keirstead HS, Blakemore WF. 1999. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination. Adv Exp Med Biol 468: 183-197.
21. Kerstetter AE, Padovani-Claudio DA, Bai L, Miller RH. 2009. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Exp Neurol 220: 44-56.
22. Kotter MR, Li WW, Zhao C, Franklin RJ. 2006. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26: 328-332.
23. Lampert PW, Sims JK, Kniazeff AJ. 1973. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 24: 76-85.
24. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ. 1998. Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 160: 970-978.
25. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. 2000. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74: 1415-1424.
26. Li M, Ransohoff RM. 2008. Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology. Prog Neurobiol 84: 116-131.
27. Liu L, Darnall L, Hu T, Choi K, Lane TE, Ransohoff RM. 2010. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci 30: 9074-9083.
28. Lu M, Grove EA, Miller RJ. 2002. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 99: 7090-7095.
29. Ludwin S.K. 1979. An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am J Pathol 95: 683-696.
30. Maysami S, Nguyen D, Zobel F, Pitz C, Heine S, Hopfner M, Stangel M. 2006. Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12. Neuroreport 17: 1187-1190.
31. McCandless EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS. 2008a. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am J Pathol 172: 799-808.
32. McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS. 2006. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol 177: 8053-8064.
33. McCandless EE, Zhang B, Diamond MS, Klein RS. 2008b. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc Natl Acad Sci USA 105: 11270-11275.
34. McTigue DM, Tripathi RB. 2008. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 107: 1-19.
35. Moll NM, Cossoy MB, Fisher E, Staugaitis SM, Tucky BH, Rietsch AM, Chang A, Fox RJ, Trapp BD, Ransohoff RM. 2009. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch Neurol 66: 44-53.
36. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC. 2005. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 19: 171-182.
37. Patel JR, McCandless EE, Dorsey D, Klein RS. 2010. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 107: 11062-11067.
38. Penkowa M, Hidalgo J. 2003. Treatment with metallothionein prevents demyelination and axonal damage and increases oligodendrocyte precursors and tissue repair during experimental autoimmune encephalomyelitis. J Neurosci Res 72: 574-586.
39. Redwine JM, Armstrong RC. 1998. In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol 37: 413-428.
40. Salmaggi A, Maderna E, Calatozzolo C, Gaviani P, Canazza A, Milanesi I, Silvani A, DiMeco F, Carbone A, Pollo B. 2009. CXCL12, CXCR4, and CXCR7 expression in brain metastases. Cancer Biol Ther 8: 1608-1614.
41. Stohlman SA, Bergmann CC, Lin MT, Cua DJ, Hinton DR. 1998. CTL effector function within the central nervous system requires CD4+ T cells. J Immunol 160: 2896-2904.
42. Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Hollt V, Schulz S. 2002. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: Isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22: 5865-5878.
43. Totoiu MO, Nistor GI, Lane TE, Keirstead HS. 2004. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol 187: 254-265.
44. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338: 278-285.
45. Walsh KB, Edwards RA, Romero KM, Kotlajich MV, Stohlman SA, Lane TE. 2007. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease. J Immunol 179: 1155-1165.
46. Wang FI, Stohlman SA, Fleming JO. 1990. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 30: 31-41.
47. Williamson JS, Stohlman SA. 1990. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol 64: 4589-4592.
48. Woerner BM, Warrington NM, Kung AL, Perry A, Rubin JB. 2005. Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. Cancer Res 65: 11392-11399.
49. Wu GF, Dandekar AA, Pewe L, Perlman S. 2000. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 165: 2278-2286.
50. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C. 2003. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6: 1064-1071.